These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. Villa NA; Okhuysen PC; Flores-Figueroa J; Jiang ZD; Belkind-Gerson J; Paredes M; Mohamed JA; Nair P; Carlin L; DuPont HL J Travel Med; 2011; 18(1):56-8. PubMed ID: 21199144 [TBL] [Abstract][Full Text] [Related]
43. The role of antiglycolipid antibodies in neurological disorders. Fredman P Ann N Y Acad Sci; 1998 Jun; 845():341-52. PubMed ID: 9668367 [TBL] [Abstract][Full Text] [Related]
44. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337 [TBL] [Abstract][Full Text] [Related]
45. Human and chicken antibodies to gangliosides following infection by Campylobacter jejuni. Usuki S; Taguchi K; Cawthraw SA; Shibata K; Ariga T; Newell DG; Yu RK Exp Neurol; 2006 Jul; 200(1):50-5. PubMed ID: 16500643 [TBL] [Abstract][Full Text] [Related]
46. [A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis]. Sugie K; Murata K; Ikoma K; Suzumura A; Takayanagi T Rinsho Shinkeigaku; 1998 Jan; 38(1):42-5. PubMed ID: 9597909 [TBL] [Abstract][Full Text] [Related]
47. T cell response in acute motor axonal neuropathy. Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468 [TBL] [Abstract][Full Text] [Related]
48. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits. Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608 [TBL] [Abstract][Full Text] [Related]
49. [Antibody response following Campylobacter infections determined by ELISA]. Engberg JH; Strid MA; Mølbak K; Krogfelt KA Ugeskr Laeger; 2003 Jun; 165(24):2485-6. PubMed ID: 12872469 [TBL] [Abstract][Full Text] [Related]
50. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model. Kirkpatrick BD; Lyon CE; Porter CK; Maue AC; Guerry P; Pierce KK; Carmolli MP; Riddle MS; Larsson CJ; Hawk D; Dill EA; Fingar A; Poly F; Fimlaid KA; Hoq F; Tribble DR Clin Infect Dis; 2013 Oct; 57(8):1106-13. PubMed ID: 23840001 [TBL] [Abstract][Full Text] [Related]
51. [Serological response to Campylobacter jejuni infection: enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to Campylobacter jejuni]. Arita K; Yamauchi E; Mizuno S; Maki S Kansenshogaku Zasshi; 1982 Jul; 56(7):566-73. PubMed ID: 6818294 [No Abstract] [Full Text] [Related]
52. [Myocarditis and pericarditis in connection with Campylobacter jejuni infection]. Melby K; von der Lippe E; Bruun JN Tidsskr Nor Laegeforen; 1992 Feb; 112(4):475-6. PubMed ID: 1553694 [TBL] [Abstract][Full Text] [Related]
53. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [TBL] [Abstract][Full Text] [Related]
54. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection. Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754 [TBL] [Abstract][Full Text] [Related]
55. [Evaluation of immunological efficiency induced by Campylobacter jejuni PEB1 DNA combined with PEB1 protein in mice]. Liu L; Lai W; Hu N; Zhang W; Chen T; Wang F; Gu R Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):576-80. PubMed ID: 24909276 [TBL] [Abstract][Full Text] [Related]
58. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M; Takahashi M; Masuda M; Hirata K; Yuki N Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859 [TBL] [Abstract][Full Text] [Related]
59. [Detection of antibodies to Campylobacter jejuni in pediatrics patients with Gullain-Barré syndrome using different antigen preparations]. Rokosz N; Rastawicki W; Jagielski M; Hetkowska-Abramczyk Z Med Dosw Mikrobiol; 2011; 63(3):255-61. PubMed ID: 22184920 [TBL] [Abstract][Full Text] [Related]
60. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection. Tang J; Yuan J; Hao H Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]